3
Announcements
Trials
Browse
Landscape
Status
Unknown
5
Recruiting
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Carcinoma, Non-Small-Cell Lung
22
Breast Neoplasms
8
Stomach Neoplasms
7
Lung Neoplasms
7
Small Cell Lung Carcinoma
5
Rectal Neoplasms
5
Pancreatic Neoplasms
5
Colorectal Neoplasms
5
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Esophageal Squamous Cell Carcinoma
4
Recurrence
3
NSCLC
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Nasopharyngeal Carcinoma
2
Muscle-invasive Bladder Cancer
2
Multiple Myeloma
2
Mesothelioma, Malignant
2
Limited Stage Small Cell Lung Cancer
2
Leukemia, Myeloid, Acute
2
Esophageal Neoplasms
2
Urologic Neoplasms
1
Upper Tract Urothelial Carcinoma
1
Thymus Neoplasms
1
Sleep Initiation and Maintenance Disorders
1
Resectable Non-small Cell Lung Cancer
1
Pathologic Complete Response
1
Interventions
surufatinib
1
irinotecan sucrosofate
1
envafolimab
1
anlotinib
1
Vincristine
1
Temozolomide
1
Proton Therapy
1
Positron Emission Tomography Computed Tomography
1
Neoadjuvant Therapy
1
Methotrexate
1
Ifosfamide
1
Etoposide
1
Epirubicin
1
Drug Therapy
1
Brachytherapy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Osteosarcoma
×
Drug Therapy
×
Clear all
NCT06776198
2025-01-24
PTMTO
Peking University People's Hospital
Not yet recruiting
100 enrolled